Form 4: Lilly Endowment Inc. Sells $162 Million Worth of Eli Lilly & Co. Stock

Lilly Endowment Inc., a major shareholder of Eli Lilly & Co., sold a significant portion of its holdings on March 3, 2025, reducing its position by approximately $162 million.

Summary

• Lilly Endowment Inc. reported the sale of Eli Lilly & Co. (LLY) common stock on March 3, 2025.
• The sales were executed in multiple transactions at varying prices throughout the day.
• A total of 199,398 shares were sold at weighted average prices ranging from $922.421 to $934.889.
• Following these transactions, Lilly Endowment Inc. still beneficially owns 96,016,978 shares of Eli Lilly & Co.
• The total value of the shares sold is approximately $162 million.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale. It doesn't inherently convey positive or negative sentiment, but the size of the sale could be interpreted in various ways by the market.

Industry Context

Sales by major shareholders are often monitored by the market as they can indicate the shareholder's view on the company's future prospects or be related to portfolio rebalancing.

Stakeholder Impact

• The sale could potentially impact shareholder sentiment, depending on how the market interprets the transaction.
• The sale represents a decrease in Lilly Endowment Inc.'s stake in Eli Lilly & Co.

Key Dates